about
Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.Effects of subthalamic nucleus deep brain stimulation on emotional working memory capacity and mood in patients with Parkinson's disease.Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study.Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients.Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients.Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.An update on inherited ataxias.Connectivity Predicts deep brain stimulation outcome in Parkinson disease.Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.Clozapine: acquittal of the usual suspect.Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features.Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.Depression comorbidity in spinocerebellar ataxia.Bright light therapy in Parkinson's disease: a pilot study.Comparison of three clinical rating scales in Friedreich ataxia (FRDA).Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6.Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.Accuracy and repeatability of two methods of gait analysis - GaitRite™ und Mobility Lab™ - in subjects with cerebellar ataxia.Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds.Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patientsLong-term evolution of patient-reported outcome measures in spinocerebellar ataxiasMRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional StudyBody Mass Index Decline Is Related to Spinocerebellar Ataxia Disease ProgressionLess Is More - Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined SettingsInstability of syllable repetition in patients with spinocerebellar ataxia and Parkinson's disease
P50
Q33834518-0F3D7276-AA1E-49D7-BE7A-13833AFC15E2Q33838185-0C71CE2F-98E3-42FF-A6B3-8396C5CACF8FQ34098898-6875DEDF-D2DC-495D-840D-6338340F3588Q34173060-E8061704-5546-4C91-88A6-756F5F620D82Q34490303-83759BE9-BFEB-4C9D-9B2C-BD7EB0825444Q34630410-CBBECDCE-E030-4038-8520-283AD44A9920Q36249347-F0828A21-1066-43B9-8141-15D652AD240AQ37203409-A983007C-4077-4AA6-91DC-7E303FD2B9B8Q38740947-A0A4A411-F9B1-47CE-A3C4-607875B09DC8Q39898662-653A86D1-EBDD-441D-9118-DADA891FA708Q40532281-4A322A40-9B3F-4337-A829-87CA17174D75Q43285094-FD3B1EF1-5697-4E79-9D43-CFF4A27E3074Q45294691-9087BBF9-AA27-4C18-9293-E7746C1BEF68Q46159545-210C3DCD-0932-4672-978A-6A234EF9FA30Q47258006-BE944579-D917-46DE-B2C7-09BFCA3EB335Q48138651-098FB5F2-AEF1-486D-84D6-BFB6D7EC6E0DQ48146159-8ED5B41A-9D6E-408E-BA6B-A2C424077937Q48310729-F199FF80-D78C-444E-8A34-F9DEA1CF02F0Q48468410-A03AF776-9612-4E9F-9D87-34C73E7889D5Q48548192-3CD278D8-8C1E-4681-B4E2-0AF8D4F09E41Q48945474-1C410ABE-973D-493D-914F-FB58BBEAECAFQ49131319-68BA6D19-7911-4B6F-AC5A-E7E0872BBB27Q51295572-D13C0EFB-5596-42BD-8C4E-F11EC4FFDCA8Q52807281-C444B4B8-B2CE-4573-B240-6F08BBAE087DQ52857217-1DEBE00E-6D60-4C1C-8FE8-6059D73B64EEQ54659616-B318BDDF-C67C-4A6A-921F-14D9F6DD5E50Q56637598-30CE7558-00F3-4DF6-9DF4-A62ADBA1C86BQ56967882-C3794B48-2E38-47E9-AAA6-C7DD16E7EC09Q58694089-00C592C7-D978-466D-9E8B-EF3D72179F9CQ61610335-6714CA7E-56E2-4AF8-9F7D-FFDB45812E79Q61812316-5B718B9D-4374-4E27-AF5B-4E01B9D6B01CQ82644144-848FCF21-6D1C-4522-90D4-B03AC9013655
P50
name
Tanja Schmitz-Hübsch
@ast
Tanja Schmitz-Hübsch
@en
Tanja Schmitz-Hübsch
@nl
type
label
Tanja Schmitz-Hübsch
@ast
Tanja Schmitz-Hübsch
@en
Tanja Schmitz-Hübsch
@nl
prefLabel
Tanja Schmitz-Hübsch
@ast
Tanja Schmitz-Hübsch
@en
Tanja Schmitz-Hübsch
@nl